Heart failure patients get a digital boost: video education trial launches
NCT ID NCT07317882
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding video-call education (via WhatsApp) to standard teaching helps heart failure patients improve self-care. 100 adults with heart failure will be split into two groups: both get usual in-person education, but one group also gets a video call three months later. After six months, researchers measure self-care levels using a questionnaire. The goal is to see if remote support can make a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Digital health education via WhatsApp video calls
- What this could lead to
- If successful, this could show that remote video education improves self-care for heart failure patients, offering a convenient supplement to in-person teaching.
- What could go wrong
- This is a small, early-stage trial (100 patients) testing a behavioral intervention, not a drug. Results may not apply to all heart failure patients, and the effect on actual health outcomes is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults over 18 years of age. * Clinical diagnosis of heart failure class II, III and IV. * Ejection fraction less than or equal to 35%. * Those who have a smartphone that allows video calls. Exclusion Criteria: * Patients with impaired cognitive ability, meaning they cannot follow basic self-care and education guidelines. * Patients with acute heart failure that can be resolved by treating the underlying cause. * Patients with high comorbidity, where non-cardiac conditions pose a greater risk and have a worse prognosis than heart failure itself. * Patients enrolled in any other clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital of Jerez
Cadiz, Cádiz, 11009, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaler boost heart pumping in COPD patients?
- Can zapping the heart beat drugs for AF in heart failure?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?